Gourion, D.

De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia

Gauthier, J., Champagne, N., Lafrenière, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Côté, M., Noreau, A., et al. (2010) · Proceedings of the National Academy of Sciences

Genetics and Neurodevelopmental DisordersSchizophrenia research and treatment

Cited by 369

Anhedonia predicts poor psychosocial functioning: results from a large cohort of patients treated for major depressive disorder by general practitioners

Vinckier, F., Gourion, D., & Mouchabac, S. (2017) · European Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 201

Antidépresseurs et tolérance : déterminants et prise en charge des principaux effets indésirables

David, D. J., & Gourion, D. (2016) · L'Encéphale

Treatment of Major DepressionPsychological Treatments and Disorders

Cited by 105